Healthcare -
Biotechnology - NASDAQ - US
$ 0.3401
-5.11 %
$ 3.83 M
Market Cap
-0.01
P/E
CYCC - CAPITAL EXPENDITURES
Capital Expenditures CYCC - Cyclacel Pharmaceuticals, Inc.
-6 K
LAST VALUE
52.86%
2 YEAR CAGR
31.23%
5 YEAR CAGR
29.85%
10 YEAR CAGR